Skip to content

Stereotaxis STXS Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Stryker logo
StrykerSYK
-$654M-29.8%
ITG
Integer HoldingsITGR
-$30.65M-30.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$33.27M-60.4%
iRadimed logo
iRadimedIRMD
-$1.15M+23.5%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$4M-71.2%
Neuronetics logo
NeuroneticsSTIM
-$2.72M+22.5%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's change in accrued liabilities?
Stereotaxis (STXS) reported change in accrued liabilities of -$587K in Q1 2026.
How has Stereotaxis's change in accrued liabilities changed year-over-year?
Stereotaxis's change in accrued liabilities decreased by 11840.0% year-over-year, from $5K to -$587K.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.